Literature DB >> 1645509

Resistance to pefloxacin in Pseudomonas aeruginosa.

M Michea-Hamzehpour1, C Lucain, J C Pechere.   

Abstract

Mechanisms of resistance to pefloxacin were investigated in four isogenic Pseudomonas aeruginosa strains: S (parent isolate; MIC, 2 micrograms/ml), PT1 and PT2 (posttherapy isolates obtained in animals; MICs, 32 and 128 micrograms/ml, respectively), and PT2-r (posttherapy isolate obtained after six in vitro subpassages of PT2; MIC, 32 micrograms/ml). [2-3H]adenine incorporation (indirect evidence of DNA gyrase activity) in EDTA-permeabilized cells was less affected by pefloxacin in PT2 and PT2-r (50% inhibitory concentration, 0.27 and 0.26 microgram/ml, respectively) than it was in S and PT1 (50% inhibitory concentration, 0.04 and 0.05 microgram/ml, respectively). Reduced [14C]pefloxacin labeling of intact cells in strains PT1 and PT2 correlated with more susceptibility to EDTA and the presence of more calcium (P less than 0.05) and phosphorus in the outer membrane fractions. Outer membrane protein analysis showed reduced expression of protein D2 (47 kDa) in strains PT1 and PT2. Other proteins were apparently similar in all strains. The addition of calcium chloride (2 mM) to the sodium dodecyl sulfate-solubilized samples of outer membrane proteins, before heating and Western blotting, probed with monoclonal antibody anti-OmpF showed electrophoretic mobility changes of OmpF in strains PT1 and PT2 which were not seen in strain S. Calcium-induced changes were reversed with ethyleneglycoltetraacetate. Decreased [14C]pefloxacin labeling was further correlated with an altered lipopolysaccharide pattern and increased 3-deoxy-D-mannooctulosonic acid concentration (P less than 0.01). These findings suggested that resistance to pefloxacin is associated with altered DNA gyrase in strain PT2-r, with altered permeability in PT1, and with both mechanisms in PT2. The decreased expression of protein D2 and the higher calcium and lipopolysaccharide contents of the outer membrane could be responsible for the permeability deficiency in P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645509      PMCID: PMC245041          DOI: 10.1128/AAC.35.3.512

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

1.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

2.  Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.

Authors:  Y Inoue; K Sato; T Fujii; K Hirai; M Inoue; S Iyobe; S Mitsuhashi
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

3.  In vitro activity of enoxacin compared with norfloxacin and amikacin.

Authors:  P van der Auwera; G de Moor; G Lacroix; A Mambour; N Rossion; F Schuyteneer
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

4.  Colorimetric determination of inorganic phosphate in the presence of biological material and adenosine triphosphate.

Authors:  M G Stanton
Journal:  Anal Biochem       Date:  1968-01       Impact factor: 3.365

Review 5.  Antibiotic uptake into gram-negative bacteria.

Authors:  R E Hancock; A Bell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

6.  Emergence of resistance to imipenem in Pseudomonas aeruginosa.

Authors:  M J Lynch; G L Drusano; H L Mobley
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

7.  Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.

Authors:  D M Benbrook; R V Miller
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.

Authors:  N J Robillard; A L Scarpa
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

9.  Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene.

Authors:  W A Woodruff; R E Hancock
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

10.  Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.

Authors:  J Blaser; M N Dudley; D Gilbert; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

View more
  12 in total

Review 1.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.

Authors:  L J Piddock; M C Hall; F Bellido; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats.

Authors:  O F Join-Lambert; M Michéa-Hamzehpour; T Köhler; F Chau; F Faurisson; S Dautrey; C Vissuzaine; C Carbon; J Pechère
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa.

Authors:  T Köhler; M Michea-Hamzehpour; P Plesiat; A L Kahr; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 5.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa.

Authors:  S A Dunham; C J McPherson; A A Miller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-23       Impact factor: 3.267

7.  Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells.

Authors:  I García; A Pascual; M C Guzman; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

8.  Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa.

Authors:  H Huang; R E Hancock
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

9.  In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.

Authors:  M Michéa-Hamzehpour; A Kahr; J C Pechère
Journal:  Infection       Date:  1994       Impact factor: 3.553

10.  Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.

Authors:  G G Zhanel; J A Karlowsky; M H Saunders; R J Davidson; D J Hoban; R E Hancock; I McLean; L E Nicolle
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.